Keyword: Harvard University

A Harvard-led team has built brain organoids that mimic the cell types and connections that every human brain has.

The week’s biotech discoveries included compounds in broccoli and ragweed with potential disease-fighting properties.

Semma and Harvard scientists are reporting they've figured out how to regenerate high quantities of insulin-producing beta cells.

Verve Therapeutics is launching with $58.5 million access to CRISPR and base-editing tech and cardiologist and geneticist Sekar Kathiresan as CEO.

Sherlock Bio hounded down new investors for its series A round, bringing on additional AI expertise to help develop its CRISPR-based diagnostics.

Deerfield is contributing up to $65 million to create a company to speed the route to market for drugs discovered at the University of Illinois at Chicago.

The goal is to genetically modify and differentiate stem cells to create cell therapies that are cloaked from the immune system.

Sherlock Biosciences is launching with $35 million and a two-pronged approach to improving the current state of diagnostics.

Deerfield Management and Harvard University are setting up a new company dubbed Lab1636, with $100 million in backing from Deerfield.

The week’s biotech news included a novel method for halting the spread of malaria and new insight into how HIV weathers an immune attack.